Escherichia coli O26 is recognized as an emerging pathogen associated with disease in both ruminants and humans. Compared to those of E. coli O157:H7, the shedding pattern and location of E. coli O26 in the gastrointestinal tract (GIT) of ruminants are poorly understood. In the studies reported here, an stx-negative E. coli O26 strain of ovine origin was inoculated orally into 6-week-old lambs and the shedding pattern of the O26 strain was monitored by serial bacteriological examination of feces. The location of colonization in the GIT was examined at necropsy at two time points. The numbers of O26 organisms excreted in feces declined from approximately 10 7 to 10 4 CFU per gram of feces by day 7 and continued at this level for a further 3 weeks. Beyond day 30, excretion was from few animals, intermittent, and just above the detection limit. By day 38, all fecal samples were negative, but at necropsy, O26 organisms were recovered from the upper GIT, specifically the ileum. However, no attaching-effacing (AE) lesions were observed. To identify the location of E. coli O26 within the GIT early after inoculation, two lambs were examined postmortem, 4 days postinoculation. High numbers of O26 organisms were recovered from all GIT sites examined, and ϳ10 9 CFU were recovered from 1 gram of ileal tissue from one animal. Despite high numbers of O26 organisms, AE lesions were identified on the mucosa of the ascending colon of only one animal. These data indicate that E. coli O26 readily colonizes 6-week-old lambs, but the sparseness of AE lesions suggests that O26 is well adapted to this host, and mechanisms other than those dependent upon intimin may play a role in persistence.Attaching-effacing Escherichia coli (AEEC) strains associated with human gastrointestinal disease are classified as either enteropathogenic E. coli (EPEC) or enterohemorrhagic E. coli (EHEC), depending on their abilities to produce Shiga toxins (41). Although E. coli O157:H7 is the most prevalent EHEC serotype associated with serious disease in humans, non-O157:H7 EHEC strains represent an emerging threat to public health and, unlike O157 strains, to animal health also (24). Indeed, non-O157 EHEC may be more prevalent than serogroup O157 in some countries (3).E. coli O26 is a well-recognized EPEC serogroup associated with disease in humans, notably infantile diarrhea (36). Significantly, Shiga toxin-elaborating E. coli (STEC) O26 bacteria are also associated with serious human infections, including severe diarrhea with sequelae similar to those of EHEC infections. Such infections have been recorded in Italy (55), Ireland (38), Japan (28, 29), Scotland (51), and elsewhere. The World Health Organization (WHO) has identified O26 STEC as the second most important serogroup of E. coli (65).EHEC and EPEC belong to the AEEC pathotype whose bacteria attach intimately to the microvillus brush border of enterocytes of animals and humans, forming attaching-effacing (AE) lesions (47, 57). The genes encoding the classical AE histopathology are located on a pat...